Clinical significance of estrogen receptor phosphorylation.
about
Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancersResting blood flow in the skin: does it exist, and what is the influence of temperature, aging, and diabetes?Serine 216 phosphorylation of estrogen receptor α in neutrophils: migration and infiltration into the mouse uterusRegulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1Parabens and Human Epidermal Growth Factor Receptor Ligand Cross-Talk in Breast Cancer CellsPhosphorylation of serine 212 confers novel activity to human estrogen receptor α.The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivo.ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer.Palmitoylation: a protein S-acylation with implications for breast cancer.Tyrosine phosphatase Shp2 mediates the estrogen biological action in breast cancer via interaction with the estrogen extranuclear receptor.Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions.Regulation of transcriptional activation function of rat estrogen receptor α (ERα) by novel C-terminal splice insertsThe Effects of 17β-estradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma Membrane.Selective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86.NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms.Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancerIKBKE Upregulation is Positively Associated with Squamous Cell Carcinoma of the Lung In Vivo and Malignant Transformation of Human Bronchial Epithelial Cells In Vitro.Post-translational modifications of nuclear receptors and human diseaseMed1 plays a critical role in the development of tamoxifen resistance.Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients.Estrogen receptor-beta and breast cancer: translating biology into clinical practiceThe Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells.Stable inhibition of specific estrogen receptor α (ERα) phosphorylation confers increased growth, migration/invasion, and disruption of estradiol signaling in MCF-7 breast cancer cells.Endocrine resistance in breast cancer--An overview and update.Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.Estrogen receptors and human disease: an update.The Predominant Proteins that React to the MC-20 Estrogen Receptor Alpha Antibody Differ in Molecular Weight between the Mammary Gland and Uterus in the Mouse and Rat.Phosphorylation of estrogen receptor α at serine 118 is correlated with breast cancer resistance to tamoxifenMediator of ERBB2-driven cell motility (MEMO) promotes extranuclear estrogen receptor signaling involving the growth factor receptors IGF1R and ERBB2β-Catenin Is a Positive Regulator of Estrogen Receptor-α Function in Breast Cancer Cells.Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.Prolactin activates ERα in the absence of ligand in female mammary development and carcinogenesis in vivoOverview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patients.Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancerLigand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305.Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy.Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro.Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer.Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance.The role of estrogen receptor α in the regulation of bone and growth plate cartilage.
P2860
Q26798324-0C93AD69-0FC1-49B2-97CD-74777B841D55Q26998382-E1DFF0E8-4B0F-418A-A07C-365C4F21AF04Q28538001-01F4188D-EC39-4710-8430-C43CA45FF0E4Q28569016-C3321D28-B7E9-441F-9230-84B283C49E99Q29109837-CEB9F551-B6FF-4098-9C95-B08554D2DBD8Q33662026-82F9F451-7B9F-429A-AFB3-2A0A8986569EQ33827011-2D4A750D-D087-45B5-B34A-9B17E5F5DE41Q33836140-5C38BA4D-C447-4309-8B41-BA2DDD2CC722Q33915087-7662DFBC-EB7C-4C72-BACA-DA4287168CDDQ33928558-99027436-D21C-4051-91F4-2B4C9D421257Q34648456-CCEF0F15-42E3-4FBA-ABAF-2E4695186F9EQ35034330-6743D6F3-8338-4120-A11D-45258B88F5BCQ35084708-734931FA-B89C-4D08-9C1E-7BEFA75E8A41Q35437491-0CBC9E07-C741-4D55-B2D1-E6C3C0BFAD7AQ35469769-6915DF66-4C3B-4624-945F-A1F9237F643CQ35674177-E1CE1D1F-E211-4831-B06A-053304B67D9DQ35703096-04233245-FA1A-4CD9-A075-804852882155Q35842790-01C50DC7-558F-4FF0-85B7-70FB759A868AQ35883606-E65A784B-59DF-478F-AECE-E6B728CBE687Q35951881-CD1A7D74-1F57-4E08-95FB-F51A45E4CDF4Q35973424-289E9B28-76D3-4083-81E6-0692FBDCA6F7Q36131503-8FCEE3E1-BA18-4E7F-B4AA-DCDEA1C842DAQ36177436-090979A6-D55D-45A5-ABA9-5C06A2B876D8Q36386322-040D7962-C525-48F0-BC0A-7EBCC1D3EE75Q36578211-53302BE5-15C0-41AA-842E-D72C1D0C8E1FQ36661810-359C60AF-6B12-4C2F-88B5-36744800B019Q36735733-9702FC36-F140-40D6-86D5-76B14C8B70F1Q37092904-8C005EC2-AA44-4F0E-A649-92B5B2299FD0Q37112684-12981A35-5D9F-4C49-A46B-B4514D4DFE63Q37137376-E197A632-3CEA-4B7E-A8C3-80F5DEE09EE9Q37217695-E2F0524F-83D4-4951-B684-D39FEE3E6569Q37331101-0D32CE75-AB9D-4BA6-946A-DF20223A7C0BQ37444430-3A0ABC7E-398E-4461-820A-BC9DDF1DE757Q37571441-185CC61C-B619-487E-89CF-62E5692EC4B8Q37632309-60C4547E-DCAA-49F2-AAA7-9BCBCC84DE5EQ37655166-6C862D14-54B3-4026-9F17-C630852AC2A9Q37690245-ADB3A138-A3EC-40EA-84D3-45248058E10FQ37728635-14A704BB-D032-4875-A5D2-E996EBE1599DQ37962586-92E00121-14A2-451A-B8A1-B41569395D21Q38091660-83F425E3-584B-47AA-8332-0A6A8D17F503
P2860
Clinical significance of estrogen receptor phosphorylation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical significance of estrogen receptor phosphorylation.
@en
Clinical significance of estrogen receptor phosphorylation.
@nl
type
label
Clinical significance of estrogen receptor phosphorylation.
@en
Clinical significance of estrogen receptor phosphorylation.
@nl
prefLabel
Clinical significance of estrogen receptor phosphorylation.
@en
Clinical significance of estrogen receptor phosphorylation.
@nl
P356
P1476
Clinical significance of estrogen receptor phosphorylation.
@en
P2093
Peter H Watson
Srinivas V Seekallu
P356
10.1677/ERC-10-0070
P577
2011-01-19T00:00:00Z